Skip to content

Publication

Introducing LigoSpace: Advancing Bioactivity Prediction at NeurIPS 2025

· Nanyang Biologics

Nanyang Biologics is excited to share that its latest research, LigoSpace, developed in collaboration with Nanyang Technological University Singapore (NTU), has been presented at NeurIPS 2025 — one of the world's most prestigious conferences in AI and ML.

LigoSpace extends our DTIGN line of work, advancing bioactivity prediction by combining molecular docking signals with self-attention mechanisms over a curated chemical space.

The collaboration with NTU is part of our broader strategy of pairing deep technology with the deep tradition of natural healing in our region. The full paper will be made available shortly — sign up to NYB Research Briefs to be notified.

Research Briefs

Subscribe to NYB Research Briefs

Monthly digest of our AI drug discovery progress, publications, and longevity science.

By submitting this form, you consent to Nanyang Biologics processing your personal data in accordance with our Privacy Policy and Singapore's Personal Data Protection Act (PDPA).